Abiopharma

🔍 Hogan Michael James (Executive)

Company: GLOBALFOUNDRIES Inc. (GFS)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 1,800 shares of Ordinary Shares at $48.31 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,995.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 150 shares of Ordinary Shares (Direct)
  Date: 2026-04-15 | Code: G | equity_swap_involved: 0 | shares_owned_after: 18,845.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The reporting person is subject to a lock-up agreement that expires on May 10, 2026 that was entered into with the underwriters in connection with an offering of securities by the issuer's majority shareholder. The sale and gift of shares are a permissible exemption under the terms of the lock-up agreement. The sale and gift reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person prior to the offering.